Correlation Between Pacira BioSciences, and Collegium Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Collegium Pharmaceutical, you can compare the effects of market volatilities on Pacira BioSciences, and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Collegium Pharmaceutical.
Diversification Opportunities for Pacira BioSciences, and Collegium Pharmaceutical
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pacira and Collegium is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Collegium Pharmaceutical go up and down completely randomly.
Pair Corralation between Pacira BioSciences, and Collegium Pharmaceutical
Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Collegium Pharmaceutical. In addition to that, Pacira BioSciences, is 2.17 times more volatile than Collegium Pharmaceutical. It trades about -0.05 of its total potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.03 per unit of volatility. If you would invest 3,437 in Collegium Pharmaceutical on August 24, 2024 and sell it today you would lose (396.00) from holding Collegium Pharmaceutical or give up 11.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pacira BioSciences, vs. Collegium Pharmaceutical
Performance |
| Timeline |
| Pacira BioSciences, |
| Collegium Pharmaceutical |
Pacira BioSciences, and Collegium Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pacira BioSciences, and Collegium Pharmaceutical
The main advantage of trading using opposite Pacira BioSciences, and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.| Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Prestige Brand Holdings |
| Collegium Pharmaceutical vs. Catalent | Collegium Pharmaceutical vs. Amphastar P | Collegium Pharmaceutical vs. ANI Pharmaceuticals | Collegium Pharmaceutical vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |